| |
| |
| Exchange: |
N/A |
| Security
Type: |
Common |
| Shares
Out: |
731,500,000 |
| Market
Cap: |
333.83(M) |
| Last
Volume: |
141,003 |
Avg
Vol: |
140,615 |
| 52
Week Range: |
$0.4199 - $1.04 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Biotechnology |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : - |
| Insider 3/6 Months : - |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Northwest Biotherapeutics is a biotechnology company focused on developing personalized immune therapies for cancer. Co. has developed a platform technology, DCVax®, which uses activated dendritic cells to mobilize a patient's own immune system to attack their cancer. Co.'s primary product, DCVax®-L, is designed to treat solid tumor cancers in which the tumor can be surgically removed. This product is in a 331-patient Phase III trial for newly diagnosed Glioblastome multiforme. Co.'s second product, DCVax®-Direct, is designed to treat inoperable solid tumors. Co. is working on preparations for Phase II trials of DCVax-Direct in various cancers, when resources permit.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
0 |
0 |
0 |
| Total Buy Value |
$0 |
$0 |
$0 |
$0 |
| Total People Bought |
0 |
0 |
0 |
0 |
| Total Buy Transactions |
0 |
0 |
0 |
0 |
| Total Shares Sold |
0 |
0 |
570,000 |
570,000 |
| Total Sell Value |
$0 |
$0 |
$469,430 |
$469,430 |
| Total People Sold |
0 |
0 |
1 |
1 |
| Total Sell Transactions |
0 |
0 |
2 |
2 |
| End Date |
2024-02-22 |
2023-11-21 |
2023-05-23 |
2022-05-23 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Hemphill Robert F Jr. |
10% Owner |
– – • |
2014-02-01 |
4 |
B |
$0.00 |
$0 |
D/D |
787,055 |
17,267,131 |
2.37 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2014-01-31 |
4 |
S |
$3.21 |
$749,034 |
D/D |
(233,344) |
16,480,076 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2014-01-17 |
4 |
B |
$0.00 |
$0 |
D/D |
5,101,366 |
16,713,420 |
2.37 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2014-01-01 |
4 |
B |
$0.00 |
$0 |
D/D |
238,248 |
11,612,054 |
2.37 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2013-12-31 |
4 |
A |
$0.00 |
$0 |
D/D |
1,330,057 |
11,373,806 |
|
- |
|
| Malik Navid |
Director |
– • – |
2013-12-17 |
4 |
B |
$0.00 |
$10 |
D/D |
10,000 |
10,000 |
2.31 |
- |
|
| Farmer Robert A |
Director |
– • – |
2013-12-04 |
4 |
B |
$5.60 |
$741,462 |
I/I |
132,404 |
132,404 |
2.1 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2013-12-01 |
4 |
B |
$0.00 |
$0 |
D/D |
277,199 |
10,043,749 |
2.37 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2013-11-01 |
4 |
B |
$0.00 |
$0 |
D/D |
257,439 |
9,766,550 |
2.37 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2013-10-31 |
4 |
B |
$0.00 |
$0 |
D/D |
223,042 |
9,509,111 |
2.37 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2013-07-31 |
4 |
B |
$4.00 |
$11,608,288 |
D/D |
2,902,072 |
9,286,069 |
2.45 |
- |
|
| Powers Linda F |
Chairperson, CEO |
• • • |
2012-12-29 |
4 |
GD |
$0.00 |
$0 |
I/I |
59,405 |
10,750,587 |
|
- |
|
| Powers Linda F |
Chairperson, CEO |
• • • |
2012-12-12 |
4 |
B |
$0.00 |
$0 |
I/I |
6,468,153 |
10,809,992 |
2.56 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2012-11-30 |
4 |
B |
$0.00 |
$0 |
D/D |
749,339 |
6,383,997 |
2.37 |
- |
|
| Jasinowski Jerry J |
Director |
– • – |
2012-10-18 |
4 |
B |
$5.60 |
$200,004 |
D/D |
35,715 |
35,715 |
2.39 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2012-10-16 |
4 |
B |
$0.00 |
$0 |
D/D |
2,759,658 |
5,634,658 |
2.37 |
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2012-10-16 |
4 |
A |
$0.00 |
$0 |
I/I |
3,149,434 |
1,715,286 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2012-10-16 |
4 |
D |
$0.00 |
$0 |
I/I |
(1,559,700) |
2,705,352 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2012-10-16 |
4 |
A |
$0.00 |
$0 |
I/I |
2,118,761 |
2,675,318 |
|
- |
|
| Jasinowski Jerry J |
Director |
– • – |
2012-10-10 |
4 |
B |
$4.80 |
$209,290 |
D/D |
43,602 |
79,317 |
2.39 |
- |
|
| Powers Linda F |
Chairperson, CEO |
• • • |
2012-07-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
950,000 |
11,385,824 |
|
- |
|
| Powers Linda F |
Chairperson, CEO |
• • • |
2012-07-24 |
4 |
GD |
$0.00 |
$0 |
D/D |
950,000 |
11,385,824 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2011-11-01 |
4 |
A |
$0.00 |
$0 |
I/I |
750,000 |
9,854,913 |
|
- |
|
| Cognate Bioservices, Inc. |
10% Owner |
– – • |
2011-10-28 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
46,000,000 |
|
- |
|
| Hemphill Robert F Jr. |
10% Owner |
– – • |
2011-10-28 |
4 |
A |
$0.20 |
$9,200,000 |
D/D |
46,000,000 |
46,000,000 |
|
- |
|
112 Records found
|
|
Page 2 of 5 |
|
|
